Briefly, dendritic cells (DCs) capture the human leukocyte antigens (HLAs) generated by cancer cells and present them on major histocompatibility complex (MHC, MHCI, and MHCII) molecules to antigen-presenting cells (APCs). This evidence concerns the gene HLA-C and cancer.